Dongsheng Tu

35PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersStochastic analysis and modellingMolecular targetsProbability theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|May 31, 2026
Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

|May 26, 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

|Mar 07, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Daniel J Renouf, James T Topham, Jonathan M Loree

|Jan 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure Proportion.

Zhanfeng Wang, Zerui Shen, Ruixing Ming

|Jul 25, 2025
Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial.

Chang Yin, Josee-Lyne Ethier, Mark S Carey

|Apr 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials.

Danielle Lilly Nicholls, Maria C Xu, Luna Zhan

Pageof 6

Frequent Collaborators

8 joint publications

Jonathan M Loree

4 joint publications

Ian Gilron

4 joint publications

Ronald R Holden

4 joint publications

Hagen F Kennecke